Target Price Raised on Energy Firm Making 'Transformative Acquisition'
Source: Streetwise Reports  (1/6/21)
The terms and benefits of Earthstone Energy's purchase of an oil and gas company, an "eye-catching act of deal making," are presented in a ROTH Capital Partners report. More >

This Tiny Digital Healthcare Company's Sales Should Rocket Higher
Source: Matt Badiali for Streetwise Reports  (1/6/21)
Independent financial analyst Matt Badiali profiles a small cap whose blood glucose monitoring system works with any smartphone. More >

Solar Energy Company Secures Bid to Build Additional 5.4MW DC Community Solar Project
Source: Streetwise Reports  (1/6/21)
UGE International reported that just prior to year-end 2020 it secured a contract to build a new US$9.9 million, 5.4MW DC community solar project in the State of Maine. More >

Explorer Discovers Fifth High-Grade Shoot at Colombia Project
Source: Streetwise Reports  (1/6/21)
The new San Juan shoot at Outcrop Gold's Santa Ana project returns 0.56 meters of 3,572 g/t silver equivalent. More >

Mining Company Drills Best Intercept at Ontario Palladium Project
Source: Streetwise Reports  (1/6/21)
Generation Mining reports the final results of its 2020 program. More >

Change Healthcare Shares Surge 30% on $7.8B Merger with UNH's OptumInsight
Source: Streetwise Reports  (1/6/21)
Change Healthcare shares rose to a new 52-week high after the company reported it will be combining its operations with UnitedHealth's OptumInsight in an all cash purchase transaction for $25.75 per share. More >

Heliostar's Unga Project Could Be an Overnight Success Story, 40 Years in the Making
Source: Matt Badiali for Streetwise Reports  (1/6/21)
Independent financial analyst Matt Badiali explains why he is closely watching Heliostar Metals' Alaska brownfields project, Unga. More >

With Palladium at Record High Prices, Miner Trading at Just a Fraction of Its NPV
Source: Thibaut Lepouttre for Streetwise Reports  (1/5/21)
Thibaut Lepouttre of Caesars Report describes how Generation Mining is "wrapping up a busy year," including publication of an "excellent" preliminary economic assessment that he expects will be followed by a feasibility study that will "optimize" the company's returns. More >

2021 Forecast Issue: Financial Navigation in Uncharted Waters
Source: Michael Ballanger for Streetwise Reports  (1/5/21)
Sector expert Michael Ballanger lays out the foundation for his investment strategy in the new year, with uranium and copper augmenting his focus on the precious metals. More >

fuboTV Shares Score Big as Firm Posts Record Q4 Gains in Subscribers & Revenue
Source: Streetwise Reports  (1/5/21)
Shares of fuboTV Inc. traded 12% higher after the live sports TV streaming platform provider announced preliminary Q4/20 revenue and subscriber growth data that exceeded prior guidance. More >

Palladium Stock Is in a Strong Long-Term Uptrend
Source: Clive Maund for Streetwise Reports  (1/5/21)
Technical analyst Clive Maund charts Generation Mining and explains why he believes the stock should go "considerably higher quite quickly." More >

This Tiny Tech Stock Is Quietly Building a Huge Business in Air Quality
Source: Matt Badiali for Streetwise Reports  (1/5/21)
Independent financial analyst Matt Badiali discusses how mCloud's technology is making it possible for office buildings to reopen during the pandemic. More >

Biopharma Recaps 2020 Accomplishments in COVID-19, Idiopathic Pulmonary Disease
Source: Streetwise Reports  (1/4/21)
Algernon Pharmaceuticals reports that it is aggressively advancing its repurposed drug, Ifenprodil. More >

Biopharma Appoints Adviser for Phase 3 COVID-19 Trial
Source: Streetwise Reports  (1/4/21)
Revive Therapeutics selects Dr. John Fahy, California-based pulmonary medicine expert and researcher, to join its team. More >

Pandion Shares Get a Lift from Positive Top-Line Data in Phase 1a Autoimmune Disease Trial
Source: Streetwise Reports  (1/4/21)
Pandion Therapeutics shares traded 35% higher after the company reported positive top-line data from its Phase 1a clinical study of PT101 for treating autoimmune diseases including ulcerative colitis and systemic lupus erythematosus. More >

StrikePoint Gold: High-Grade Silver and Gold in the Golden Triangle
Source: Erik Wetterling aka "The Hedgeless Horseman" for Streetwise Reports  (1/4/21)
Erik Wetterling, aka "The Hedgeless Horseman," provides his investment thesis for StrikePoint Gold. More >

Gold Set to Soar as Hyperinflation Looms
Source: Clive Maund for Streetwise Reports  (1/4/21)
Technical analyst Clive Maund discusses the dollar's fall and what it means for gold. More >

Gold Is Still a Bargain
Source: Peter Krauth for Streetwise Reports  (1/4/21)
Peter Krauth discusses the confluence of factors that points to the gold bull market having plenty of upside ahead. More >

Silver: A Powerful Advance Believed Imminent
Source: Clive Maund for Streetwise Reports  (1/4/21)
Technical analyst Clive Maund charts silver and explains why he believes the metal is primed to move much higher. More >

ParcelPal, a Small-Cap DoorDash, Looks Set to Achieve Three Consecutive Months of Profitability
Source: Streetwise Reports  (1/4/21)
The fast growing company offers quick delivery in the areas it serves. More >

Firm Acquires Near-Term Producing NSR Royalty in Nevada, 'Offers an Attractive Growth Profile'
Source: Streetwise Reports  (12/31/20)
This latest transaction of Ely Gold Royalties is discussed in a Noble Capital Markets report. More >

Drill Results Show 'Potential Beyond Upcoming Maiden Resource'
Source: Streetwise Reports  (12/31/20)
These latest assays from Liberty Gold's Black Pine project are reviewed in a PI Financial report. More >

Intrepid Shares Grow 40% on Positive Upward Trend for 2021 Trio and Potash Prices
Source: Streetwise Reports  (12/31/20)
Shares of Intrepid Potash Inc. sprouted to a new 52-week high after the company reported that it anticipates greater demand and higher prices for its Trio and potash products in 2021. More >

California Biotech Advances Two COVID-19 Products
Source: Streetwise Reports  (12/30/20)
Recent news concerning Sorrento Therapeutics' SARS-CoV-2 virus test and antibodies is discussed in a Dawson James Securities report. More >

Biotech On Track for Trio of Drugs in Clinical Trials in 2021
Source: Streetwise Reports  (12/30/20)
The next steps for advancing Oramed Pharmaceuticals' oral therapy candidates are provided in an H.C. Wainwright & Co. report. More >